TherapeuticsMD Inc

0 DAYS LEFT TO SEEK LEAD PLAINTIFF STATUS

Case Summary
Company Name: TherapeuticsMD Inc
Stock Symbol : NYSEMKT: TXMD
Class Period Start: 07/07/2016
Class Period End: 04/09/2017
Lead Plaintiff motion: 06/19/2017
Date Filed: 04/19/2017
Type of Case: Securities Class Action
Court: U.S. District Court for the Southern District of New York
Summary:

Thieler Law Corp advises investors with losses exceeding $100,000 of the June 19, 2017 lead plaintiff deadline in a class action lawsuit filed against TherapeuticsMD Inc (NYSEMKT: TXMD) (“TherapeuticsMD” or “the Company”). The suit is pending in the U.S. District Court for the Southern District of Florida and investors, who purchased TherapeuticsMD Inc securities between July 7, 2016 and April 9, 2017, have until June 19, 2017 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased TherapeuticsMD Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose the Company’s New Drug Application (NDA) submission for TX-004HR was deficient; the Company’s NDA submission for TX-004HR was not supported by the complete TX-004HR clinical program and/or the clinical program was deficient; the Company’s deficient NDA would likely cause a delay of the FDA’s potential approval of the TX-004HR NDA.

On April 10, 2017, TherapeuticsMD revealed in a press release that the U.S. Food and Drug Administration had identified deficiencies in its NDA for TX-004HR.

On this news, NYSEMKT: TXMD dropped over 19% to close at $6.20 per share on April 10, 2017.

If you were negatively impacted by your investment in TherapeuticsMD Inc securities between July 7, 2016 and April 9, 2017 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185

Transactions
Buy date (mm/dd/yyyy) Number of shares Price per share
Sell date (mm/dd/yyyy) Number of shares Price per share
Please wait...